North America’s medical devices industry saw a rise of 25.00% in cross border deal activity during March 2021, when compared with the last 12-month average, led by Organon &’s $240m acquisition of Alydia Health , according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 20 medical devices industry cross border deals worth $919.51m were announced for the region in March 2021, against the 12-month average of 16 deals.

Of all the deal types, venture financing saw most activity in March 2021 with ten transactions, representing a 50% share for the region.

In second place was M&A with eight deals, followed by private equity deals with two transactions, respectively capturing a 40% and 10% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in North America’s medical devices industry with $488m, while venture financing and private equity deals totalled $310.51m and $121m, respectively.

North America medical devices industry cross border deals in March 2021: Top deals

The top five medical devices cross border deals accounted for 63.4% of the overall value during March 2021.

The combined value of the top five medical devices cross border deals stood at $583m, against the overall value of $919.51m recorded for the month.

The top five medical devices industry cross border deals of March 2021 tracked by GlobalData were:

1) Organon &’s $240m acquisition of Alydia Health

2) The $110m acquisition deal with 7D Surgical by SeaSpine

3) Alumni Ventures Group , aMoon Partners , Echo Health Ventures , Khosla Ventures and Northpond Ventures ‘ $82m venture financing of Scipher Medicine

4) The $81m private equity deal with Rapid Micro Biosystems by Adage Capital Management , Ally Bridge Group , Asahi Kasei Medical , Bain Capital Life Sciences , BlackRock , CaaS Capital Management , D1 Capital Partners , Endeavour Vision , Longitude Capital Management Co, Quaker Partners Management, Sunley House Capital Management , T Rowe Price Associates and Xeraya Capital Sdn

5) TELUS Health Solutions ‘ asset transaction with Babylon Healthcare Services for $70m.